ArticleResearch (Washington, D.C.)2025
General Intelligence Framework to Predict Virus Adaptation Based on a Genome Language Model.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Decoding viral protein sequences by large language models.Briefings in bioinformatics · 2026Review
- Cell Culture Adaptation of Porcine Group A Rotavirus: Advances and Challenges for Vaccine Development.Viruses · 2026Review
- Genomic-epidemiological analysis of 15 million SARS-CoV-2 genomes reveals accelerated fitness gain of JN.1 lineage.Virologica Sinica · 2026Article
- Genomic similarity to quantitatively evaluate the reassortment potential of H7N9 with other subtypes of avian influenza viruses.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most human viral pandemics are caused by animal-originated viruses with human adaptation. It is challenging to infer adaptation from viral genes or their coded protein sequences, particularly when the data labels for modeling are inadequate or the input sequence to be predicted is incomplete. Here, we developed a semi-supervised General Intelligence framework to predict Virus Adaptation based on Language-model-embedded protein sequences (GIVAL) for blind input of virus sequences. The language model in GIVAL, named virus Bidirectional Encoder Representations from Transformers (vBERT), was pretrained for embedding using hidden Markov model-contextualized tokens of viral protein sequences. vBERT outperformed prevalent pretrained models like DNABERT-2, proteinBERT, ESM-2, Transformer, and Word2Vec on distinguishing viral proteins with various-grained labels, such as serotypes and single phenotype-altering mutation. The semi-supervised GIVAL obtained higher accuracy in virus adaptation prediction and better fault tolerance on raw labels in the training dataset, overcoming the obstacle of modeling with insufficient labels and predicting blind input. GIVAL was applicable to the adaptation prediction of diverse viruses. For influenza A viruses (IAVs), higher human adaptation was predicted for equine-origin H3N8 IAVs and bovine H5N1 IAVs with simulated mutations. For coronaviruses, GIVAL predicted an adaptation shift of receptor binding from Middle East respiratory syndrome-related coronavirus (MERS-CoV) receptor to severe acute respiratory syndrome coronavirus receptor of 2 recently reported MERS-CoV-like virus variants. For monkeypox viruses, GIVAL quantified an incremental adaptation shift of viral variants, matching the rise in human monkeypox cases. Summarily, GIVAL provides a generally intelligent framework for predicting virus adaptation based on its genotype, with the potential to extend to more genotype-to-phenotype prediction scenarios.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.